Sunday , 29 March 2015

Latest News
Home » Business & Finance » Stocks Losing Enormously: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Kennedy-Wilson Holdings Inc (NYSE:KW), Novavax, Inc (NASDAQ:NVAX), RADA Electronic Ind. Ltd (NASDAQ:RADA)
Stocks Losing Enormously: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Kennedy-Wilson Holdings Inc (NYSE:KW), Novavax, Inc (NASDAQ:NVAX), RADA Electronic Ind. Ltd (NASDAQ:RADA)

Stocks Losing Enormously: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Kennedy-Wilson Holdings Inc (NYSE:KW), Novavax, Inc (NASDAQ:NVAX), RADA Electronic Ind. Ltd (NASDAQ:RADA)

March 25, 2015 9:38 am by: Category: Business & Finance Leave a comment A+ / A-

On Tuesday, Following Stocks were among the “Top 100 Losers” In U.S. Stock Exchange: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Kennedy-Wilson Holdings Inc (NYSE:KW), Novavax, Inc (NASDAQ:NVAX), RADA Electronic Ind. Ltd (NASDAQ:RADA)

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS)’s shares dwindled -3.19%, and closed at $0.576. The stock has price to sale ratio of 4722.45, however, price to book ratio is 2.62. With recent decline, the year-to-date (YTD) performance reflected a -3.98% decline below last year. During the past month the stocks lose -2.02%, bringing three-month performance to -5.80% and six-month performance to -57.95%. The mean recommendation of analysts for this stock is 2.50. (where 1=Buy, 5=Sale).

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women’s health. The company’s product pipeline comprises MACRILEN, which accomplished the Phase 2 trial for use in the diagnosis of adult growth hormone deficiency; and zoptarelin doxorubicin, which is in Phase 3 clinical study zoptarelin doxorubicin in endometrial cancer (ZoptEC) of the compound in women with advanced, recurrent, or metastatic endometrial cancer.

Kennedy-Wilson Holdings Inc (NYSE:KW), declined -3.18%, and closed at $25.31. The company holds the market capitalization of $2.51B. For the last twelve months, the stock was able to keep return on equity at 2.40%, while return on assets at 0.40%, in response to its return on investment at -0.30%. Its 20-day moving average declined -4.21%, below 50-day moving average of -4.95%, below 200-day moving average of -1.91% from the latest market price of $ 25.31. The mean recommendation of analysts for this stock is 1.90.(where 1=Buy, 5=Sale).

Kennedy-Wilson Holdings, Inc. operates as a real estate investment and services company in the United States, the United Kingdom, Ireland, Jersey, Spain, and Japan. It operates in two segments: KW Investments and KW Services. The KW Investments segment invests in various types of real estate investments, such as commercial real estate that comprises office, industrial, retail, and mixed-use assets; and multifamily properties. This segment also offers loan originations/discounted loan purchases, which comprise individual notes on various real estate property types, in addition to portfolios of loans purchased from financial institutions, corporations, and government agencies.

Novavax, Inc (NASDAQ:NVAX), dipped -3.14%, and closed at $9.25. The stock has the beta value of 1.23, and its volatility for the week is 1.23%, while for the month it is 5.05%. The company has the market capitalization of $2.21B. The company holds the book value per share of 0.96, whereas cash per share is 0.70. Price to book ratio remained 9.64, while price to sale ratio is 72.13. Analysts mean recommendation for the stock is said to be 1.40 (where 1=Buy, 5=sale).

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline comprises respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization that are in Phase II clinical trials, in addition to pediatric respiratory syncytial virus candidate, which is in Phase I clinical trial; seasonal quadrivalent influenza and pandemic H7N9 vaccines, which are in Phase I clinical trials; vaccine candidate against Ebola Virus that is Phase I clinical trial, in addition to combination respiratory vaccine candidate, which is pre-clinical trial; and seasonal influenza vaccine candidate that is Phase III clinical trial, in addition to rabies G protein vaccine candidate, which is in Phase 1/2 clinical trial.

RADA Electronic Ind. Ltd (NASDAQ:RADA), dropped -3.10%, and closed at $2.81.The company has the market capitalization of $26.07M. The beta value of the stock is 0.75. On the other hand the stock’s volatility for the week is 28.51%, and for the month is 10.93%. The stock’s price to book ratio is 6.85, however price to sale ratio is 1.08.

RADA Electronic Industries Ltd., a defense electronics contractor, is engaged in the development, manufacture, and sale of defense electronics to various air forces and companies worldwide. The company offers data/video recording and administration systems, counting flight data recorders for fighter aircraft; digital video/audio/data recorders with data transfer functions; high-rate data recorders for aircraft and airborne pods; video recorders and airborne data servers; a range of head-up-displays color video cameras for fighter aircraft; and various ground debriefing solutions. It also provides inertial navigation systems (INS), such as fiber optic gyro based navigation-grade embedded GPS-INS; micro-electro mechanical systems (MEMS) based multiple-sensor aided INS for combat platforms and weapons; modular avionics and MEMS-based INS for unmanned aircraft vehicles (UAVs) and disposable applications; and inertial measurement units.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.

Stocks Losing Enormously: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Kennedy-Wilson Holdings Inc (NYSE:KW), Novavax, Inc (NASDAQ:NVAX), RADA Electronic Ind. Ltd (NASDAQ:RADA) Reviewed by on . On Tuesday, Following Stocks were among the "Top 100 Losers" In U.S. Stock Exchange: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Kennedy-Wilson Holdings Inc (NYS On Tuesday, Following Stocks were among the "Top 100 Losers" In U.S. Stock Exchange: AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Kennedy-Wilson Holdings Inc (NYS Rating: 0

Leave a Comment

scroll to top